Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02187965 · ClinicalTrials.gov registry record
Impact of Muscle Fat Accumulation on the Genomic Profile of Skeletal Muscle in Older Adults
A clinical trial, sponsored by Purdue University.
- Completed
- Registry status
- 11
- Enrollment target
NCT02187965: Completed study, sponsored by Purdue University.
NCT02187965 is a clinical trial that has completed, run by Purdue University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02187965 has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Subjects were asked to come to the Purdue facilities after an overnight fast on 2 different testing days for 2.5 hours each day. On one day the subjects participated in blood pressure and body weight measurements as well as a muscle biopsy from the thigh. On the second day the subjects underwent an MRI and MRS scan of the thigh and calf.
Primary Outcome
To determine the within day reproducibility of MRI scans for intermuscular adipose tissue (IMAT) quantification in older men and women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-08 |
What the finished NCT02187965 record still lists
NCT02187965 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02187965 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02187965 about?
NCT02187965 is a clinical study titled "Impact of Muscle Fat Accumulation on the Genomic Profile of Skeletal Muscle in Older Adults". Subjects were asked to come to the Purdue facilities after an overnight fast on 2 different testing days for 2.5 hours each day. On one day the subjects participated in blood pressure and body weight measurements as well as a muscle biopsy from the thigh. On the second day the subjects underwent an ...
What is the current status of trial NCT02187965?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2011-08. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT02187965?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia